
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
Enlaza Therapeutics is pioneering the field of covalent biologics. These novel classes of protein therapeutics deliver more efficacious and safer treatments for patients. The companys proprietary War-LockTM platform leverages leading synthetic biology technology for site-specific covalent coupling driven by drug binding. Enlaza is building a pipeline of first-in-class covalent biologics
Biotech,antibody drug conjugates,covalent biologics,covalent protein drugs,and oncology
Enlaza therapeutics operates in the Biotechnology research industry.
Enlaza therapeutics's revenue is 11m - 100m
Enlaza therapeutics has 51 - 200 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.